TheraRadar
Clinical-Stage Companies / Azidus Brasil

Azidus Brasil

Pre-Approval PRO BETA
🟡

Slowing Activity

No new clinical trials started in 1-2 years. Monitor for changes in pipeline strategy. Last trial started: 2/1/2025

39
Total Trials
25
Phase 3
9
Phase 2
0
Recruiting
477
Score

Pipeline by Phase

Phase 3
25
Phase 2
9
Phase 1
10

Therapeutic Focus

Healthy Cardiac Surgery Healthy Subjects covid19 Huntington Disease

Clinical Trials (39)

NCT06817096 Phase 3 NOT YET RECRUITING

Efficacy and Safety of Nitazoxanide 600 Mg in the Outpatient Treatment of COVID-19 and Influenza

Started: 2/1/2025

NCT01125761 Phase 3 WITHDRAWN

Efficacy and Safety of the Association Drugs in Patients With Allergic Dermatitis

Started: 11/1/2010

NCT01666249 Phase 3 SUSPENDED

Clinical Efficacy of Postpartum Immunization of Rh and Coombs Negative Women With Sensitization Risk.

Started: 4/1/2014

NCT01227876 Phase 3 COMPLETED

Clinical Efficacy of the Drug Ster® Compared With Predfort® in Control of Postoperative Inflammation in Cataract Surgery

Started: 1/1/2011

NCT01055756 Phase 3 WITHDRAWN

Clinical Trial Of The Effectiveness Of The Product Cloratadd D (Loratadine + Pseudoephedrine Sulfate) Produced By The Laboratory EMS S/A, Compared To The Drug Claritin D Produced By Schering-Plough S/A, In Patients With Allergic Rhinitis

Started: 1/1/2010

NCT01695759 Phase 3 TERMINATED

Clinical Efficacy of Two Erythropoietin Drug in Participants With Secondary Anemia to Chronic Kidney Disease.

Started: 12/1/2013

NCT01228630 Phase 3 COMPLETED

Effectiveness of Two Preparations of Loratadine + Pseudoephedrine in Patients With Perennial Allergic Rhinitis.

Started: 8/1/2011

NCT01180348 Phase 3 COMPLETED

Efficacy and Safety of a New Botulinum Toxin Type A for Treatment of Facial Expression Lines

Started: 8/1/2011

NCT01480778 Phase 3 COMPLETED

Evaluation of Ciclo 21® Effect (Levonorgestrel + Ethinyl Estradiol) Compared to Nordette®.

Started: 7/1/2014

NCT00912483 Phase 3 WITHDRAWN

Efficacy of Sodium Heparin in Prophylaxis of Venous Thromboembolism in Surgical Patients

Started: 5/1/2010

NCT00894985 Phase 3 COMPLETED

Efficacy and Safety of Sodium Heparin

Started: 6/1/2009

NCT00894998 Phase 3 COMPLETED

Efficacy and Safety of Sodium Heparin in Patients (Cristália)

Started: 6/1/2009

NCT00857688 Phase 3 COMPLETED

Efficacy of the Combination Bismuth + Neomycin + Procaine in the Treatment of Recurrent Aphthous Ulceration

Started: 5/1/2011

NCT00894829 Phase 3 COMPLETED

Efficacy and Safety of Sodium Heparin (Eurofarma)

Started: 6/1/2009

NCT00894673 Phase 3 COMPLETED

Efficacy and Safety of Sodium Heparin (Hipolabor) in Patients

Started: 7/1/2009

NCT00860873 Phase 3 COMPLETED

Effectiveness of Glucosamine + Chondroitin in Osteoarthrosis

Started: 10/1/2009

NCT00894959 Phase 3 COMPLETED

Efficacy and Safety of Sodium Heparin in Patients

Started: 7/1/2009

NCT01100632 Phase 3 SUSPENDED

Effectiveness Evaluation of Panax Ginseng, Vitamins and Minerals in Improvement of Stress and Fatigue

Started: 9/1/2010

NCT00673426 Phase 3 COMPLETED

Safety Evaluation of Use Sodic Enoxaparin

Started: 1/1/2008

NCT03252535 Phase 2 COMPLETED

Dose-response Evaluation of the Cellavita HD Product in Patients With Huntington's Disease

Started: 1/15/2018

NCT01229072 Phase 2 SUSPENDED

Safe Use of Heparin Sodium in Patients With Chronic Renal Failure.

Started: 7/1/2008

NCT00701623 Phase 2 WITHDRAWN

Sodic Heparin Effectiveness of the Treatment of Burns

Started: 6/1/2008

NCT00701974 Phase 2 SUSPENDED

Non-inferiority Clinic of Kollagenase® Compared Iruxol® in Treatment of Cutaneous Ulcers

Started: 2/1/2008

NCT00717652 Phase 2 SUSPENDED

Efficiency And Safety Of Association Arbutin, Triamcinolone And Tretinoin In Treatment Of Melasma

Started: 7/1/2008

NCT04441398 Phase 2 WITHDRAWN

Efficacy and Safety of Nitazoxanide 600 mg to Treat Mild Ambulatory COVID-19 Patients

Started: 7/1/2020

NCT04435314 Phase 2 WITHDRAWN

Efficacy and Safety of Nitazoxanide for Post Exposure Prophylaxis of COVID-19

Started: 6/1/2020

NCT04315987 Phase 2 COMPLETED

NestaCell® Mesenchymal Stem Cell to Treat Patients With Severe COVID-19 Pneumonia

Started: 6/30/2020

NCT00715975 Phase 2 COMPLETED

Effectiveness and Safety of Topical Halobetasol Propionate in the Treatment of Patients With Psoriasis

Started: 7/1/2008

NCT01086982 Phase 1 SUSPENDED

Pharmacodynamics Of Product Octreotide Acetate Lar 30 Mg Compared To Product Sandostatin LAR ®

Started: 3/1/2010

NCT03572647 Phase 1 COMPLETED

Pharmacokinetics and Pharmacodynamics Assessment of Drug Eritromax Compared to Eprex in Healthy Subjects.

Started: 11/1/2012

NCT01692717 Phase 1 COMPLETED

Clinical Assessment Of Association Pharmacokinetics Atorvastatin + Losartana + Hydrochlorothiazide

Started: 2/28/2013

NCT01692171 Phase 1 COMPLETED

Pharmacodynamics Study of Enoxalow Compared to Clexane in Healthy Subjects After Intravenous Administration

Started: 2/28/2013

NCT01692158 Phase 1 COMPLETED

Pharmacodynamics Study of Enoxalow Compared to Clexane in Healthy Subjects After Subcutaneous Single Dose

Started: 3/1/2013

NCT01685333 Phase 1 COMPLETED

PK and PD Crossover Study After Single Dose, Intravenous Administration of Two Epoetin Alfa, Human Recombinant Epoetin and Eprex, in Healthy Subjects.

Started: 2/28/2013

NCT01685359 Phase 1 COMPLETED

PK and PD Parallel Study After Multiple Dose, Intravenous Administration of Two Epoetin Alfa, Human Recombinant

Started: 2/28/2013

NCT01549301 Phase 1 COMPLETED

Evaluation of Pharmacokinetic and Pharmacodynamic Parameters of Filgrastim (G-CSF)Produced by Blausiegel Indústria e Comércio Ltda. Compared to Granulokine Produced by Produtos Roche Químicos e Farmacêuticos S/A.

Started: 8/1/2012

NCT01074593 Phase 1 COMPLETED

Pharmacokinetics and Pharmacodynamics of the Interferon Beta-1a Produced by Laboratorio Quimico Farmaceutico Bergamo Compared to Interferon Beta-1a (Rebif - Merck Serono) in Healthy Subjects

Started: 1/1/2011

NCT01071005 Phase 1 COMPLETED

Pharmacodynamics of Lorelin Depot (Leuprorelin Acetate - Bergamo) Compared to Lupron Depot ® (Leuprorelin Acetate - Abbot)

Started: 8/1/2010

NCT05603403 Phase 4 COMPLETED

Efficacy And Safety Of Probiatop In The Treatment Of Digestive Symptoms

Started: 10/20/2022

Drug Candidates

Cellavita HD lower dose Cellavita HD higher dose Nitazoxanide 600Mg Oral Tablet / placebo oral tablet Probiatop Heparin sodic heparin liquemine heparin folder water dexamethasone 0.5 mg and 1.0 mg clemastine cream Dexamethasone 0,5 mg cream
Activity Status: Slowing
Last Trial Started: 2/1/2025
Last Trial Ended: 3/15/2023
Trials (12 months): 0
Completed Trials: 25
Data sourced from ClinicalTrials.gov. This company has no FDA-approved drugs.